Page last updated: 2024-08-22

lutetium and Abnormalities, Autosome

lutetium has been researched along with Abnormalities, Autosome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baidoo, KE; Brechbiel, MW; Milenic, DE; Yong, KJ	1

Other Studies

1 other study(ies) available for lutetium and Abnormalities, Autosome

Article	Year
Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts. International journal of molecular sciences, 2016, May-16, Volume: 17, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chromosome Aberrations; Colonic Neoplasms; DNA Breaks, Double-Stranded; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunoconjugates; Injections, Intraperitoneal; Linear Energy Transfer; Lutetium; Mice, Nude; Neoplasm Transplantation; Rad51 Recombinase; Radioimmunotherapy; Radioisotopes; Reverse Transcriptase Polymerase Chain Reaction; Trastuzumab; Xenograft Model Antitumor Assays	2016

Article

Year

Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.

International journal of molecular sciences, 2016, May-16, Volume: 17, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chromosome Aberrations; Colonic Neoplasms; DNA Breaks, Double-Stranded; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunoconjugates; Injections, Intraperitoneal; Linear Energy Transfer; Lutetium; Mice, Nude; Neoplasm Transplantation; Rad51 Recombinase; Radioimmunotherapy; Radioisotopes; Reverse Transcriptase Polymerase Chain Reaction; Trastuzumab; Xenograft Model Antitumor Assays

2016